Cargando…

Hemoglobin α and β are ubiquitous in the human lung, decline in idiopathic pulmonary fibrosis but not in COPD

BACKGROUND: Idiopathic pulmonary fibrosis (IPF) and chronic obstructive pulmonary disease (COPD) are disorders of the lung parenchyma. They share the common denominators of a progressive nature and poor prognosis. The goal was to use non-biased proteomics to discover new markers for these diseases....

Descripción completa

Detalles Bibliográficos
Autores principales:	Ishikawa, Nobuhisa, Ohlmeier, Steffen, Salmenkivi, Kaisa, Myllärniemi, Marjukka, Rahman, Irfan, Mazur, Witold, Kinnula, Vuokko L
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2949726/ https://www.ncbi.nlm.nih.gov/pubmed/20836851 http://dx.doi.org/10.1186/1465-9921-11-123

Ejemplares similares

Airway biomarkers of the oxidant burden in asthma and chronic obstructive pulmonary disease: Current and future perspectives
por: Louhelainen, Noora, et al.
Publicado: (2008)

Variability in the precursor proteins of collagen I and III in different stages of COPD
por: Harju, Terttu, et al.
Publicado: (2010)

Increased oxidative stress in asymptomatic current chronic smokers and GOLD stage 0 COPD
por: Rytilä, Paula, et al.
Publicado: (2006)

Matrix metalloproteinases -8, -9 and -12 in smokers and patients with Stage 0 COPD
por: Ilumets, Helen, et al.
Publicado: (2007)

Glutathione-S-transferases in lung and sputum specimens, effects of smoking and COPD severity
por: Harju, Terttu, et al.
Publicado: (2008)

Glutathione S-transferase omega in the lung and sputum supernatants of COPD patients
por: Harju, Terttu H, et al.
Publicado: (2007)

Ageing and long-term smoking affects KL-6 levels in the lung, induced sputum and plasma
por: Ishikawa, Nobuhisa, et al.
Publicado: (2011)

Ageing and smoking contribute to plasma surfactant proteins and protease imbalance with correlations to airway obstruction
por: Ilumets, Helen, et al.
Publicado: (2011)

Pharmacological treatment of idiopathic pulmonary fibrosis – preclinical and clinical studies of pirfenidone, nintedanib, and N-acetylcysteine
por: Myllärniemi, Marjukka, et al.
Publicado: (2015)

mMRC dyspnoea scale indicates impaired quality of life and increased pain in patients with idiopathic pulmonary fibrosis
por: Rajala, Kaisa, et al.
Publicado: (2017)

Comparison between the disease-specific Airways Questionnaire 20 and the generic 15D instruments in COPD
por: Mazur, Witold, et al.
Publicado: (2011)

Modulation of glutaredoxin in the lung and sputum of cigarette smokers and chronic obstructive pulmonary disease
por: Peltoniemi, Mirva J, et al.
Publicado: (2006)

Factor analysis identifies three separate symptom clusters in idiopathic pulmonary fibrosis
por: Seppälä, Severi, et al.
Publicado: (2020)

Idiopathic pulmonary fibrosis - a systematic review on methodology for the collection of epidemiological data
por: Kaunisto, Jaana, et al.
Publicado: (2013)

Overall drug treatment of idiopathic pulmonary fibrosis patients from national registries – a real-world study from Finland
por: Kaunisto, Jaana, et al.
Publicado: (2023)

Elevation of sputum matrix metalloproteinase-9 persists up to 6 months after smoking cessation: a research study
por: Louhelainen, Noora, et al.
Publicado: (2010)

End-of-life care of patients with idiopathic pulmonary fibrosis
por: Rajala, Kaisa, et al.
Publicado: (2016)

Delay and inequalities in the treatment of idiopathic pulmonary fibrosis: the case of two Nordic countries
por: Pesonen, Ida, et al.
Publicado: (2018)

Hemoglobin Expression in Nonerythroid Cells: Novel or Ubiquitous?
por: Saha, Debarchana, et al.
Publicado: (2014)

Demographics and survival of patients with idiopathic pulmonary fibrosis in the FinnishIPF registry
por: Kaunisto, Jaana, et al.
Publicado: (2019)

KIF15 missense variant is associated with the early onset of idiopathic pulmonary fibrosis
por: Hollmén, Maria, et al.
Publicado: (2023)

Organisation of diagnosis and treatment of idiopathic pulmonary fibrosis and other interstitial lung diseases in the Nordic countries
por: Bendstrup, Elisabeth, et al.
Publicado: (2015)

Label-free plasma proteomics identifies haptoglobin-related protein as candidate marker of idiopathic pulmonary fibrosis and dysregulation of complement and oxidative pathways
por: Saraswat, Mayank, et al.
Publicado: (2020)

Sputum Vitamin D Binding Protein (VDBP) GC1S/1S Genotype Predicts Airway Obstruction: A Prospective Study in Smokers with COPD
por: Gao, Jing, et al.
Publicado: (2020)

NO Dioxygenase Activity in Hemoglobins Is Ubiquitous In Vitro, but Limited by Reduction In Vivo
por: Smagghe, Benoit J., et al.
Publicado: (2008)

Diffuse Alveolar Damage: A Common Phenomenon in Progressive Interstitial Lung Disorders
por: Kaarteenaho, Riitta, et al.
Publicado: (2011)

Gremlin-1 Overexpression in Mouse Lung Reduces Silica-Induced Lymphocyte Recruitment – A Link to Idiopathic Pulmonary Fibrosis through Negative Correlation with CXCL10 Chemokine
por: Koli, Katri, et al.
Publicado: (2016)

Are physicians in primary health care able to recognize pulmonary fibrosis?
por: Purokivi, Minna, et al.
Publicado: (2017)

DNA methylation profiling in peripheral lung tissues of smokers and patients with COPD
por: Sundar, Isaac K., et al.
Publicado: (2017)

Effect Declines Are Systematic, Strong, and Ubiquitous: A Meta-Meta-Analysis of the Decline Effect in Intelligence Research
por: Pietschnig, Jakob, et al.
Publicado: (2019)

NF-κB Inducing Kinase, NIK Mediates Cigarette Smoke/TNFα-Induced Histone Acetylation and Inflammation through Differential Activation of IKKs
por: Chung, Sangwoon, et al.
Publicado: (2011)

Nitric oxide-induced eosinophil apoptosis is dependent on mitochondrial permeability transition (mPT), JNK and oxidative stress: apoptosis is preceded but not mediated by early mPT-dependent JNK activation
por: Ilmarinen-Salo, Pinja, et al.
Publicado: (2012)

Gremlin-1 is a key regulator of the invasive cell phenotype in mesothelioma
por: Yin, Miao, et al.
Publicado: (2017)

Persistence of oxidant and protease burden in the airways after smoking cessation
por: Louhelainen, Noora, et al.
Publicado: (2009)

Antioxidant therapies in COPD
por: Rahman, Irfan
Publicado: (2006)

Lung function decline in COPD
por: Tantucci, Claudio, et al.
Publicado: (2012)

Marked deterioration in the quality of life of patients with idiopathic pulmonary fibrosis during the last two years of life
por: Rajala, K., et al.
Publicado: (2018)

The ubiquitous quasidisk
por: Gehring, Frederick W, et al.
Publicado: (2012)

Ubiquitous Amyloids
por: Pulawski, Wojciech, et al.
Publicado: (2012)

Successful Smoking Cessation in COPD: Association with Comorbidities and Mortality
por: Kupiainen, H., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_jp854igvgd05km5vp99oldatvl